Healthcare Equipment and Supplies
Company Overview of Bausch & Lomb Incorporated
Bausch & Lomb Incorporated develops, manufactures, and markets eye care products. Its products include contact lens with wearing modalities; lens care products, such as chemical disinfectants for soft contact lenses, as well as Boston line of products for cleaning GP contact lenses; and prescription and over-the-counter pharmaceutical medicines to treat a range of eye conditions, including glaucoma, eye allergies, conjunctivitis, dry eye, and retinal diseases. The company also provides a line of Rx products, which include the antibacterial eye drops, the steroid eye drops, and retinal diseases treatment products; daily eye vitamins; and cataract and vitreoretinal surgery products, such as in...
400 Somerset Corporate Boulevard
Bridgewater, NJ 08807
Founded in 1853
Key Executives for Bausch & Lomb Incorporated
Corporate Vice President and President of Latin America Operations
President of Asia-Pacific
Chief Medical Officer and Executive Vice President
Senior Vice President and General Manager of Vision Care
Compensation as of Fiscal Year 2017.
Bausch & Lomb Incorporated Key Developments
Bausch + Lomb Introduces Ocuvite Eye Vitamin Adult 50+ Formula Minigels
Sep 6 17
Bausch + Lomb announced the launch of Ocuvite (R) Adult 50+ Formula Minigel daily eye vitamins that help replenish vital nutrients that eyes can lose as they age. The new minigels, which will replace the currently offered Ocuvite (R) Adult 50+ soft gels, now include highly concentrated fish oil, helping to make them 25% smaller and easier to swallow. More than half of U.S adults are aware that nutrients and vitamins are helpful in maintaining eye health, yet only 18% have ever taken supplements specifically for eye health. People understand the importance of vitamins and nutrients to support overall health and wellness; however, many people may not be getting the vital nutrients necessary to support eye health specifically. Ocuvite (R) Adult 50+ Formula provides vital eye nutrients, including Lutein, Zeaxanthin and Omega-3.
Bausch + Lomb Officially Opens EUR 85 Million Extension at Waterford, Ireland Facility
Jul 31 17
Bausch + Lomb officially opened a EUR 85 million extension at the company's Waterford, Ireland facility to help meet the consumer demand of its contact lens portfolio, specifically Biotrue(R) ONEday daily disposable contact lenses. Valeant Pharmaceuticals International, the parent company of Bausch + Lomb, has invested more than EUR 200 million in the Waterford facility's operations, infrastructure and manufacturing line growth. This investment, supported by the Department of Business, Enterprise and Innovation through IDA Ireland, has created 125 additional jobs, bringing the total to 300 since the Waterford facility expansion first began in 2015. As a result of the expansion, approximately 112,000 sq. ft. of new building has been added to a 17-acre site adjacent to its current facility. This brings the total footprint of the complex to 500,000 sq. ft.
Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX® Contact Lenses
Jul 6 17
Valeant Pharmaceuticals International Inc.'s wholly owned subsidiary, Bausch + Lomb announced the introduction of Bausch + Lomb AQUALOX® contact lenses, the first new innovation in the bi-weekly contact lens category in half a decade, to the Japanese market. The innovative bi-weekly silicone hydrogel lens combines MoistureSeal® technology, which helps the lens maintain 95% of its moisture up to a full 16 hours, and provides patients maximum comfort throughout the day. In addition to the Bausch + Lomb AQUALOX lenses, the Bausch + Lomb Japan product portfolio features PureVision®2, SofLens® 59, and SofLens® 38 bi-weekly contact lenses, renu® fresh solution, the No. 1 multi-purpose contact lens solution in Japan, as well as the following daily disposable contact lenses, Biotrue® ONEday, Biotrue ONEday for Presbyopia, and Medalist® ONEday.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|